Statistics for Sutro Biopharma (id:6651 STRO)

Valuation metrics

Market cap

226.76M

Enterprise value

-125,084,288.00

Trailing P/E (ttm)

-1.41

Forward P/E

-0.92

PEG ratio

-0.92

Price/Sales (ttm)

1.41

Price/Book (mrq)

1.51

Enterprise Value/Revenue

-0.78

Enterprise Value/EBITDA

1.02

Overview

Shares outstanding

82.46M

Float

69.31M

Shares short

2.40M

% Held by insiders

0.01%

% Held by institutions

0.77%

Average volume (10 days)

725.13K

Average volume (90 days)

Price summary

52-Week low

2.13

52-Week high

6.13

52-Week change

9.16%

Beta

1.17

50-Day moving average

3.74

200-Day moving average

4.00

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-77.01%

Operating margin

-797.17%

Operational effectiveness

Return on assets

-18.40%

Return on equity

-110.89%

Income statement

Revenue (ttm)

2.25

Revenue per share (ttm)

2.25

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-122,962,000.00

Net income to common (ttm)

-123,953,000.00

Diluted EPS (ttm)

-1.55

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

388.25M

Total cash per share (mrq)

4.71

Total debt (mrq)

24.86M

Total Debt/Equity (mrq)

22.36

Current ratio (mrq)

309.10%

Book value per share (mrq)

1.82

Cash flow

Cash flow statement

-105,730,000.00

Levered free cash flow (LFCF)

754.62K